24 May 2013
Keywords: vertex/gsk, lexiva, shown, promising, new, hiv, therapy
Article | 02 February 2004
Final 48-week results from the NEAT trial, published in the January issue of the Journal of Acquired Immune Deficiency Syndrome, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 February 2004
© 2013 thepharmaletter.com